Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation

被引:0
|
作者
Ying Gao
Na Lu
Yun Ling
Yan Chen
Ling Wang
Qing Zhao
Qi Qi
Wei Liu
Haiwei Zhang
Qidong You
Qinglong Guo
机构
[1] China Pharmaceutical University,Jiangsu Key Laboratory of Carcinogenesis and Intervention
关键词
Oroxylin A; Angiogenesis; VEGF; KDR/Flk-1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:667 / 675
页数:8
相关论文
共 50 条
  • [1] Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation
    Gao, Ying
    Lu, Na
    Ling, Yun
    Chen, Yan
    Wang, Ling
    Zhao, Qing
    Qi, Qi
    Liu, Wei
    Zhang, Haiwei
    You, Qidong
    Guo, Qinglong
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (05) : 667 - 675
  • [2] Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1
    Lu, Na
    Yang, Yong
    You, Qi-Dong
    Ling, Yun
    Gao, Ying
    Gu, Hong-Yan
    Zhao, Li
    Wang, Xiao-Tang
    Guo, Qing-Long
    [J]. CANCER LETTERS, 2007, 258 (01) : 80 - 89
  • [3] Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation
    Kwak, HJ
    Park, MJ
    Park, CM
    Moon, SI
    Yoo, DH
    Lee, HC
    Lee, SH
    Kim, MS
    Lee, HW
    Shin, WS
    Park, IC
    Rhee, CH
    Hong, SI
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) : 2711 - 2720
  • [4] KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells
    Yoshiji, H
    Kuriyama, S
    Hicklin, DJ
    Huber, J
    Yoshii, J
    Miyamoto, Y
    Kawata, M
    Ikenaka, Y
    Nakatani, T
    Tsujinoue, H
    Fukui, H
    [J]. HEPATOLOGY, 1999, 30 (05) : 1179 - 1186
  • [5] Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1
    Chen, HH
    Zhou, HJ
    Wu, GD
    Lou, XE
    [J]. PHARMACOLOGY, 2004, 71 (01) : 1 - 9
  • [6] Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus
    Herve, MAJ
    Meduri, G
    Petit, FG
    Domet, TS
    Lazennec, G
    Mourah, S
    Perrot-Applanat, M
    [J]. JOURNAL OF ENDOCRINOLOGY, 2006, 188 (01) : 91 - 99
  • [7] Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas
    Pakos, EE
    Goussia, AC
    Tsekeris, PG
    Papachristou, DJ
    Stefanou, D
    Agnantis, NJ
    [J]. ANTICANCER RESEARCH, 2005, 25 (05) : 3591 - 3596
  • [8] Hypoxia inducible factor 1 alpha, vascular endothelial growth factor and Kdr/Flk-1 overexpression in ischemic colitis
    Okuda, T
    Azuma, T
    Satomi, S
    Ohtani, M
    Masaki, R
    Ito, Y
    Suto, H
    Yamazaki, Y
    Ito, S
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A658 - A658
  • [9] Signal transduction of vascular endothelial growth factor (VEGF) receptors, Flt-1 and KDR/Flk-1
    Shibuya, M
    Takahashi, T
    Sawano, A
    Hiratsuka, S
    Ogawa, S
    Yabana, N
    Maru, Y
    Noda, T
    Yamaguchi, S
    [J]. TISSUE ENGINEERING FOR THERAPEUTIC USE 3, 1999, 1175 : 25 - 33
  • [10] The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells
    Albini, A
    Soldi, R
    Giunciuglio, D
    Giraudo, E
    Benelli, R
    Primo, L
    Noonan, D
    Salio, M
    Camussi, G
    Rockl, W
    Bussolino, F
    [J]. NATURE MEDICINE, 1996, 2 (12) : 1371 - 1375